Largest health care biotech companies by market cap

Amgen leads the 24 health care biotech companies ranked by market value, at NZ$434B, ahead of Gilead Sciences (NZ$378.8B) and Moderna (NZ$143.9B). Figures as of 19 Nov 2026, 11:55 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
AmgenNZ$434B
Median
NZ$19.2B
Combined market value
NZ$1.51T
Countries
5

Market values as of .

All countries
Health Care
Biotech
NZD
Clear filters
Largest health care biotech companies by market cap
#CompanyMarket cap ↓PriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareNZ$434BNZ$802.33 3.07% down 32% up United States
2Gilead SciencesGILD · Health CareNZ$378.8BNZ$305.43 0.75% down 35% up United States
3ModernaMRNA · Health CareNZ$143.9BNZ$355.70 4.84% down 780% up United States
4argenxARGX · Health CareNZ$107BNZ$1,701.31 0.66% down 2% up Belgium
5BiogenBIIB · Health CareNZ$67.2BNZ$454.42 0.25% up 49% up United States
6Revolution MedicinesRVMD · Health CareNZ$62.5BNZ$288.87 1.76% down 129% up United States
7BioNTechBNTX · Health CareNZ$37.3BNZ$150.49 1.89% down 14% down Germany
8ExelixisEXEL · Health CareNZ$30.1BNZ$123.43 0.31% down 63% up United States
9Neurocrine BiosciencesNBIX · Health CareNZ$29.8BNZ$294.37 1.84% down 17% up United States
10Bio-TechneTECH · Health CareNZ$20.7BNZ$131.50 0.17% up 24% up United States
11RepligenRGEN · Health CareNZ$20BNZ$312.10 6.47% up 12% up United States
12Halozyme TherapeuticsHALO · Health CareNZ$19.7BNZ$173.16 0.18% down 39% up United States
13Kymera TherapeuticsKYMR · Health CareNZ$18.7BNZ$218.94 0.32% down 87% up United States
14QiagenQGEN · Health CareNZ$18.5BNZ$89.58 0.38% down 9% up Netherlands
15Krystal BiotechKRYS · Health CareNZ$16.9BNZ$569.98 5.62% up 54% up United States
16VaxcytePCVX · Health CareNZ$16.7BNZ$105.77 1.48% down 23% up United States
17Twist BioscienceTWST · Health CareNZ$14.3BNZ$210.30 3.88% up 346% up United States
18CG OncologyCGON · Health CareNZ$12.9BNZ$144.60 1.34% up 97% up United States
19ImmunityBioIBRX · Health CareNZ$12.9BNZ$12.11 7.03% up 232% up United States
20ImmunovantIMVT · Health CareNZ$12.4BNZ$59.95 0.12% down 46% up United States
21Kodiak SciencesKOD · Health CareNZ$11.6BNZ$176.79 1.04% up 399% up United States
22Scholar Rock HoldingSRRK · Health CareNZ$10.6BNZ$86.76 6.48% up 26% up United States
23Adaptive BiotechnologiesADPT · Health CareNZ$8.3BNZ$51.44 0.11% down 74% up United States
24CRISPR TherapeuticsCRSP · Health CareNZ$7BNZ$72.64 0.10% up 18% down Switzerland

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 1.8075 NZD).

Questions and answers

Which health care biotech companies rank first by market value?

Amgen (NZ$434B), Gilead Sciences (NZ$378.8B) and Moderna (NZ$143.9B) are the top three of the 24 health care biotech companies ranked by market value as of 19 Nov 2026, 11:55 UTC.

How many health care biotech companies are in this ranking?

24 are ranked by market value.

What are these health care biotech companies worth together?

The 24 health care biotech companies ranked by market value have a combined market value of NZ$1.51T as of 19 Nov 2026, 11:55 UTC.

What does ranking by market value measure?

What the stock market values the whole company at: its share price times the number of its shares.

Cite this page

Funkfolio, “Largest health care biotech companies by market cap”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care

Underlying data: Yahoo Finance; SEC EDGAR.